Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

MICAFUNGIN SODIUM

MICAFUNGIN SODIUM

Standard Dose
EQ 50MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview MICAFUNGIN SODIUM is listed in Drugs@FDA under application 219712 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient MICAFUNGIN SODIUM Form and strength INJECTABLE;INTRAVENOUS - EQ 50MG BASE/VIAL Sponsor HISUN PHARM HANGZHOU Submission history Latest submission status date: 2026-01-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview MICAFUNGIN SODIUM is listed in Drugs@FDA under application 219712 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MICAFUNGIN SODIUM Form and strength INJECTABLE;INTRAVENOUS - EQ 50MG BASE/VIAL Sponsor HISUN PHARM HANGZHOU Submission history Latest submission status date: 2026-01-21 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.